Wednesday, May 11, 2011
PDL BioPharma Inc., of Incline Village, Nev., said it intends to offer $135 million worth of new convertible senior notes due May 2015. Underwriter BofA Merrill Lynch will have an option to purchase $20.25 million worth of additional notes to cover any overallotments.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.